Maria Ines Mitrani, Chief Science Officer at Organicell Regenerative Medicine, Inc. (BPSR), sold 250,000 shares at $0.14 ($34K) on 2021-06-04, disclosed to the SEC on 2021-06-08.
Open-market sale of $34k BPSR by Chief Science Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.14 | 10,000 | $1K | 4.2% |
| 2 | $0.14 | 40,000 | $6K | 16.7% |
| 3 | $0.14 | 50,000 | $7K | 20.9% |
| 4 | $0.12 | 50,000 | $6K | 17.9% |
| 5 | $0.13 | 50,000 | $7K | 19.4% |
| 6 | $0.14 | 50,000 |
| $7K |
| 20.9% |
| Total | $0.13 avg | 250,000 | $34K | 100% |
| Filing → |
| BPSR | SELL | 2021-06-11 | $31K | — | Filing → |
| BPSR | SELL | 2021-06-03 | $24K | — | Filing → |
| BPSR | SELL | 2021-05-28 | $26K | — | Filing → |